Celularity Inc. Operating Cash Flow
Celularity Inc. (CELU) reported Operating Cash Flow of -$13.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-04-30
- Celularity Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.10M, a 420.14% decline year-over-year.
- Celularity Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.16M.
- Celularity Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$999.00K.
- Celularity Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$2.99M.
- Celularity Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$13.25M.
- Celularity Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$6.40M.
- Celularity Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$38.69M.
- Celularity Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$137.88M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | -$9.26M derived: sum of 2 quarters · filed 2026-04-30 | -$10.26M derived: sum of 3 quarters · filed 2026-04-30 | -$13.25M 10-K · filed 2026-04-30 | ||||||
| 2025-09-30 | -$4.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$5.16M derived: sum of 2 quarters · filed 2025-11-14 | -$8.15M 10-Q · filed 2025-11-14 | -$6.56M derived: sum of 4 quarters · filed 2026-04-30 | ||||||
| 2025-06-30 | -$999.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | -$3.99M 10-Q · filed 2025-08-29 | -$2.40M derived: sum of 3 quarters · filed 2026-04-30 | -$2.54M derived: sum of 4 quarters · filed 2026-04-30 | ||||||
| 2025-03-31 | -$2.99M 10-Q · filed 2025-08-29 | -$1.40M derived: sum of 2 quarters · filed 2026-04-30 | -$1.54M derived: sum of 3 quarters · filed 2026-04-30 | -$4.99M derived: sum of 4 quarters · filed 2026-04-30 | ||||||
| 2024-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $1.45M derived: sum of 2 quarters · filed 2026-04-30 | -$2.00M derived: sum of 3 quarters · filed 2026-04-30 | -$6.40M 10-K · filed 2026-04-30 | ||||||
| 2024-09-30 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.59M derived: sum of 2 quarters · filed 2025-11-14 | -$8.00M 10-Q · filed 2025-11-14 | -$12.34M derived: sum of 4 quarters · filed 2025-11-14 | ||||||
| 2024-06-30 | -$3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | -$7.85M 10-Q · filed 2025-08-29 | -$12.19M derived: sum of 3 quarters · filed 2025-08-29 | -$20.51M derived: sum of 4 quarters · filed 2025-08-29 | ||||||
| 2024-03-31 | -$4.40M 10-Q · filed 2025-08-29 | -$8.74M derived: sum of 2 quarters · filed 2025-08-29 | -$17.07M derived: sum of 3 quarters · filed 2025-08-29 | -$28.09M derived: sum of 4 quarters · filed 2025-08-29 | ||||||
| 2023-12-31 | -$4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | -$12.66M derived: sum of 2 quarters · filed 2025-05-08 | -$23.69M derived: sum of 3 quarters · filed 2025-05-08 | -$38.69M 10-K · filed 2025-05-08 | ||||||
| 2023-09-30 | -$8.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | -$19.35M derived: sum of 2 quarters · filed 2024-12-06 | -$34.34M 10-Q · filed 2024-12-06 | -$63.93M derived: sum of 4 quarters · filed 2024-12-06 | ||||||
| 2023-06-30 | -$11.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$26.02M 10-Q · filed 2024-11-07 | -$55.61M derived: sum of 3 quarters · filed 2024-11-07 | -$93.33M derived: sum of 4 quarters · filed 2024-11-07 | ||||||
| 2023-03-31 | -$14.99M 10-Q · filed 2024-10-16 | -$44.58M derived: sum of 2 quarters · filed 2024-10-16 | -$82.30M derived: sum of 3 quarters · filed 2024-10-16 | -$118.62M derived: sum of 4 quarters · filed 2024-10-16 | ||||||
| 2022-12-31 | -$29.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$67.31M derived: sum of 2 quarters · filed 2024-07-30 | -$103.62M derived: sum of 3 quarters · filed 2024-07-30 | -$137.88M 10-K · filed 2024-07-30 | ||||||
| 2022-09-30 | -$37.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | -$74.04M derived: sum of 2 quarters · filed 2024-01-03 | -$108.29M 10-Q · filed 2024-01-03 | -$140.34M derived: sum of 4 quarters · filed 2024-01-03 | ||||||
| 2022-06-30 | -$36.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$70.57M 10-Q · filed 2023-08-14 | -$102.62M derived: sum of 3 quarters · filed 2023-08-14 | -$137.39M derived: sum of 4 quarters · filed 2023-08-14 | ||||||
| 2022-03-31 | -$34.25M 10-Q · filed 2023-05-22 | -$66.30M derived: sum of 2 quarters · filed 2023-05-22 | -$101.07M derived: sum of 3 quarters · filed 2023-05-22 | -$119.27M derived: sum of 4 quarters · filed 2023-05-22 | ||||||
| 2021-12-31 | -$32.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$66.82M derived: sum of 2 quarters · filed 2023-03-31 | -$85.02M derived: sum of 3 quarters · filed 2023-03-31 | -$110.10M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | -$34.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$52.97M derived: sum of 2 quarters · filed 2022-11-10 | -$78.05M 10-Q · filed 2022-11-10 | -$94.88M derived: sum of 4 quarters · filed 2022-11-10 | ||||||
| 2021-06-30 | -$18.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$43.28M 10-Q · filed 2022-08-09 | -$828.94K 10-Q · filed 2021-08-19 | -$60.11M derived: sum of 3 quarters · filed 2022-08-09 | -$105.70M derived: sum of 4 quarters · filed 2022-08-09 | |||||
| 2021-03-31 | -$25.08M 10-Q · filed 2022-05-16 | -$446.09K 10-Q · filed 2021-05-24 | -$41.91M derived: sum of 2 quarters · filed 2022-05-16 | -$87.50M derived: sum of 3 quarters · filed 2022-05-16 | -$87.72M derived: sum of 4 quarters · filed 2022-05-16 | |||||
| 2020-12-31 | -$16.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$62.42M derived: sum of 2 quarters · filed 2022-03-31 | -$62.64M derived: sum of 3 quarters · filed 2022-03-31 | -$63.19M 10-K · filed 2022-03-31 | -$1.18M 10-K · filed 2021-03-04 | |||||
| 2020-09-30 | -$45.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$45.81M derived: sum of 2 quarters · filed 2021-11-12 | -$46.36M 10-Q · filed 2021-11-12 | -$938.71K 10-Q · filed 2020-11-16 | -$46.59M derived: sum of 4 quarters · filed 2021-11-12 | |||||
| 2020-06-30 | -$224.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | -$774.01K 10-Q · filed 2021-08-19 | -$997.81K derived: sum of 3 quarters · filed 2021-08-19 | -$1.68M derived: sum of 4 quarters · filed 2021-08-19 | ||||||
| 2020-03-31 | -$549.58K 10-Q · filed 2021-05-24 | -$773.38K derived: sum of 2 quarters · filed 2021-05-24 | -$1.45M derived: sum of 3 quarters · filed 2021-05-24 | -$1.65M derived: sum of 4 quarters · filed 2021-05-24 | ||||||
| 2019-12-31 | -$223.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$903.02K derived: sum of 2 quarters · filed 2021-05-24 | -$1.10M derived: sum of 3 quarters · filed 2021-05-24 | -$1.10M 10-K/A · filed 2021-05-24 | ||||||
| 2019-09-30 | -$679.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$873.35K derived: sum of 2 quarters · filed 2020-11-16 | -$874.03K 10-Q · filed 2020-11-16 | |||||||
| 2019-06-30 | -$194.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$194.81K 10-Q · filed 2020-08-13 | ||||||||
| 2019-03-31 | -$676.00 10-Q · filed 2020-05-15 | |||||||||
| 2018-12-31 | -$543.00 10-K · filed 2020-03-24 | |||||||||
| 2018-09-30 | -$545.00 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |